Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00336505 · ClinicalTrials.gov registry record · Phase 3
Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)
A Phase 3 study, sponsored by Advanced Life Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 584
- Enrollment target
NCT00336505: Completed Phase 3 study, sponsored by Advanced Life Sciences.
NCT00336505 is a Phase 3 study that has completed, run by Advanced Life Sciences. The registered enrollment target is 584 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00336505, a Phase 3 study, has completed, sponsored by Advanced Life Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 584 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the efficacy of cethromycin to clarithromycin for the treatment of mild to moderate community-acquired pneumonia (CAP).
Primary Outcome
Investigators evaluated subjects for a clinical response of cure, failure, or indeterminate. Cure: Improvement or return to preinfection state or lack of progression of all pulmonary infiltrates, and resolution of all signs/symptoms present at enrollment. Failure: Persistence or worsening of signs/symptoms, the need for additional antibiotic, new pulmonary infection, progression of the chest radiograph, or death due to pneumonia. Indeterminate: Evaluation was not possible (lost to follow up, adv
Interventions
- DRUG Clarithromycin
- DRUG Cethromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 584 participants |
| Start Date | 2005-12 |
| Est. Completion | 2007-10 |
| Phase | Phase 3 |
What the finished NCT00336505 record still lists
NCT00336505 is an interventional study that assigns participants to a tested intervention. The registered 584 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (24% lower).
The record links to 0 conditions, and to 2 interventions - of which Clarithromycin is the first listed.
NCT00336505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00336505 about?
NCT00336505 is a clinical study titled "Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)". The purpose of this study is to compare the efficacy of cethromycin to clarithromycin for the treatment of mild to moderate community-acquired pneumonia (CAP).
What is the current status of trial NCT00336505?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 584 participants. The study started on 2005-12. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00336505?
The interventions under investigation include: Clarithromycin (DRUG), Cethromycin (DRUG).
Who is sponsoring clinical trial NCT00336505?
This trial is sponsored by Advanced Life Sciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00336505's enrollment target sits among peer trials
584 652nd of 2000 higher than 1,349 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
- NCT04984291 · 584 participants · NA
Zimmer Biomet Shoulder Arthroplasty PMCF
- NCT05983757 · 584 participants · NA
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
- NCT06569290 · 584 participants · NA
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia